Company Name Biocept
Mailing Address 5810 Nancy Ridge Drive San Diego, CA 92121 USA
Company Description Biocept (NASDAQ: BIOC) is a leader in genetic testing. The company’s proprietary CEE Cell Enrichment and Extraction technology is designed to isolate and extract rare cells for highly accurate genetic analysis. CEE will be used exclusively in Biocept Laboratories’ first product, preCEEd prenatal diagnostic.
Proceeds Purposes Proceeds purposes were not disclosed. 1 investor participated in the offering. Amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.